Tazepam

Quick links to important sections

Tazepam

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tazepam

What is Tazepam? Defining the Drug's Identity

Here are some quick facts about Tazepam (oxazepam):

Property Description
Active ingredient Oxazepam (INN)
Form Oral tablets or capsules
Pharmacological class Benzodiazepine
Common use Anxiety and insomnia
Origin Synthetic (man-made)

The Identity and Class of Tazepam

Tazepam is a brand name for the generic prescription drug oxazepam, which belongs to the benzodiazepine class of medicines and is primarily used to treat anxiety and insomnia. Oxazepam is officially classified as an anxiolytic (anti-anxiety) and a sedative-hypnotic. It acts as a minor tranquilizer on the central nervous system (CNS), promoting calmness and relaxation.

The oxazepam active ingredient is unique among some benzodiazepines because it undergoes direct glucuronidation in the liver and does not produce active metabolites. This pharmacological trait often makes it a preferred option for patient groups with impaired liver function or for the elderly, where drug accumulation is a significant concern.

The Origin and General Therapeutic Purpose

The active ingredient in Tazepam is oxazepam, a pharmacologically synthetic compound manufactured entirely through chemical synthesis in a laboratory environment. Tazepam is an intermediate-acting drug, meaning its effects are generally recognized as having a more gradual onset compared to ultra-fast-acting agents in its class.

It is used for its therapeutic properties as a CNS depressant, which is clinically recognized for its role in managing acute, moderate-to-severe symptoms of anxiety and sleep disturbances where anxiety is a primary component. Furthermore, oxazepam is a standard agent for managing the symptoms of alcohol withdrawal syndrome. Its core purpose is to provide relief by calming nervous activity and promoting a sedative state for short-term clinical intervention.

Regulatory References

  1. NIH - StatPearls - Oxazepam

What side effects are possible with Tazepam?

Possible Side Effects and Safety Information

The officially documented adverse effects of Tazepam (oxazepam) primarily relate to its function as a central nervous system (CNS) depressant. The safety profile, as defined in regulatory documents, outlines risks based on frequency, the organ systems affected, and the duration of exposure.

Documented Adverse Reactions

Side effects are most commonly reported as drowsiness, sedation, dizziness, and lethargy. These CNS-related effects are generally classified as common and are explicitly noted to be transient, often being seen in the first few days of therapy. Less frequent reactions can involve the Nervous System (e.g., slurred speech, tremor, headache) and Psychiatric Disorders, where paradoxical effects like mild excitement, confusion, or agitation have been documented.

Serious Safety Considerations

The regulatory labels specify rare but clinically significant adverse reactions, including the potential for leukopenia (a blood disorder) and signs of hepatic dysfunction such as jaundice. Furthermore, the medicine is formally classified as a Schedule IV controlled substance due to the documented risk of developing physical and psychological dependence, particularly with prolonged use. Abrupt or rapid cessation may precipitate acute and potentially severe withdrawal reactions.

Population-Specific Notes

The official prescribing information includes specific safety cautions for certain groups. Older adults are noted to have an increased susceptibility to the CNS depressant effects, including dizziness and lightheadedness, which increases the risk for falls. Caution is also advised for individuals with hepatic impairment (liver problems) due to the potential for slower clearance of the medicine from the body.

Overdose and Emergency Response

Overdosage of Tazepam (oxazepam) is officially documented by regulators as a state of central nervous system (CNS) depression, ranging in severity from profound sedation and confusion to coma. Documented clinical manifestations include respiratory depression (slowed or difficult breathing), slurred speech, uncoordinated movement, and low blood pressure. More severe outcomes include breathing stops and death, risks that are significantly increased with the concomitant use of alcohol, opioids, or other CNS depressants.

Due to the risk of life-threatening events, immediate medical attention must be sought if too much oxazepam is taken or if signs of overdosage, such as trouble breathing, occur. Regulatory guidance mandates that patients or caregivers should call emergency services or the nearest hospital emergency room right away, and may also consider contacting a poison control center.

Overdose Management Elements Regulatory Statement
Primary Treatment Symptomatic and supportive treatment is the management mainstay.
Antidote Availability Flumazenil is a documented adjunct, but its use is cautioned against due to risk of precipitating seizures.
Population Risk Note Risk of low blood pressure may occur, particularly in elderly people.

The official profile requires close monitoring for signs of respiratory compromise and CNS effects throughout the duration of supportive care.

Therapeutic Uses of Tazepam

What Tazepam Treats: Main Uses and Benefits

Tazepam (oxazepam) is generally used to provide supportive relief across specific clinical contexts characterized by heightened physiological activity. It contributes to easing the overall symptom load and may assist with maintaining functional stability when symptoms intensify. The medication is utilized across therapeutic domains where additional symptomatic support is needed to address heightened patient distress.


Easing Significant Anxiety and Emotional Tension

This medication is commonly used to address anxiety disorders and anxiety that may be associated with depression. Its main uses include providing short-term symptomatic relief for conditions that may be characterized by periods of heightened symptoms that create noticeable interference with daily stability. The medication is applied in addressing the symptoms of psychological tension, excessive worry, and internal restlessness, and is considered relevant for the management of the acute phase of alcohol withdrawal syndrome.

“Tazepam is applied in settings where symptoms create noticeable functional strain and short-term symptomatic assistance is needed.”

Tazepam offers symptomatic relief that helps patients cope more steadily with difficult episodes, contributing to easing the overall symptom load of heightened emotional and physical manifestations. It is also applied in addressing sleep disturbances—specifically difficulty remaining asleepin situations where patients experience underlying worry and tension.

Quick Fact: Relief for Tension and Agitation


Stabilization during Acute Alcohol Withdrawal

Tazepam is considered relevant for the management of the acute phase of alcohol withdrawal syndrome. It is specifically used to help address the systemic instability, including severe agitation, tremulousness (shaking), and excitability that occur during cessation. Applied in clinical settings that involve acute or unstable symptom patterns, it is used for managing these intense manifestations, providing supportive relief during this challenging symptomatic phase.

Regulatory References

  1. NIH DailyMed Prescribing Information

Eligibility and Restrictions for Use

Tazepam (oxazepam) eligibility is defined by official regulatory guidelines, which strictly classify which populations are permitted, restricted, or contraindicated for use.

Populations Not Allowed (Contraindications)

Use of Tazepam is contraindicated in several high-risk groups to prevent serious adverse outcomes:

  • Patients with known hypersensitivity to oxazepam or any other benzodiazepine.
  • Individuals with Myasthenia Gravis (a neuromuscular disease).
  • Those with Severe Respiratory Insufficiency or Severe Hepatic Insufficiency (liver disease).

Restricted and Age-Group Use

The medicine is generally approved for use in adults. Specific limitations apply to other populations:

  • Pediatric Use: Safety and effectiveness are not established for children under 6 years of age. Use in older children and adolescents is restricted and requires careful consideration.
  • Older Adults: While often preferred over other benzodiazepines due to its simple metabolism, use in geriatric patients requires starting at the lowest effective dose due to increased risks of sedation and falls.
  • Pregnancy and Lactation: Use during pregnancy is not recommended, especially during the first and third trimesters, due to potential risks to the fetus and newborn. The drug is also not recommended for those who are breastfeeding as it is excreted into breast milk.

Official labeling also places restrictions on individuals with a history of alcohol or drug abuse due to the risk of addiction and misuse (Schedule IV Controlled Substance).

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Tazepam (Oxazepam)


Interaction Scope

Category Description
Medicinal product categories with documented interactions Central Nervous System (CNS) Depressants, Opioids, Glucuronidation Inhibitors, and Alcohol.
Specific interacting medicines (if explicitly listed) Opioids (as a class for regulatory restriction) and substances that inhibit UGT enzymes (e.g., Ketoprofen).
Mechanistic basis of interactions (only if stated in label) Additive CNS Depression (Pharmacodynamic); Reduced Clearance via Glucuronidation Inhibition (Pharmacokinetic).
Timing-based interaction rules (if applicable) None documented as mandatory dose separation requirements in official labels.
Population-specific interaction notes (if applicable) Elderly patients may be susceptible to hypotension; Obese patients may experience a prolonged half-life.
Interaction-related restrictions Co-administration with Opioids is subject to the FDA Boxed Warning; Alcohol use is strictly discouraged.

Interaction Classifications (High-Level)

Interaction severity classification (as defined in official documents): Highest level of regulatory caution for Opioids and Alcohol due to the documented risk of profound sedation and death.

Regulatory basis (EMA / FDA / etc.): FDA Boxed Warning; official prescribing information (DailyMed).

Interaction-context constraints (as defined in official documents): Opioid co-administration is reserved for use when alternative treatment options are inadequate.


Resulting Interaction Structure

Official interaction statements:

  • Co-administration with Opioids and other CNS depressants carries the risk of profound sedation, respiratory depression, coma, and death.
  • Concurrent use of Alcohol is strictly discouraged due to the documented risk of severe CNS depressant effects.
  • Inhibitors of Glucuronosyltransferase (UGT) enzymes may reduce clearance and increase oxazepam plasma exposure.
  • Tazepam may be administered with or without food, as the official label documents no specific drug-food interaction.

Connection to the overall interaction profile (3 sentences): Regulatory documents establish that Tazepam’s principal interaction structure is defined by a critical pharmacodynamic risk with CNS depressants and opioids, resulting in severe restrictions. The drug's pharmacokinetic interaction profile is limited to non-CYP pathways involving glucuronidation inhibition. The profile is further constrained by specific regulatory cautions against Alcohol and notes regarding patient populations with altered clearance.

Mechanism of Action

Tazepam acts as a positive allosteric modulator of the GABA A receptor complex, which is a ligand-gated chloride ion channel. The molecule binds to a distinct, non-GABA binding site located at the interface between the alpha and gamma subunits. Tazepam exhibits high affinity for GABA A receptors containing specific subunit configurations, notably the alpha 2 and gamma 2 subunits.

The binding event potentiates the inhibitory effects of the endogenous neurotransmitter GABA. This potentiation increases the frequency of chloride ion channel opening when GABA is present. The resulting influx of negatively charged chloride ions causes hyperpolarization of the postsynaptic neuron. This hyperpolarization decreases the likelihood of action potential generation and contributes to the overall inhibitory tone within the central nervous system, modulating neuronal excitability.

Dosage and Administration Information

Tazepam (oxazepam) is a prescription-only medicine belonging to the benzodiazepine class and should be taken exactly as directed by your healthcare professional. It is typically prescribed for the short-term management of anxiety disorders and the relief of acute alcohol withdrawal symptoms.

Administration and Timing

  • Oral Use: Swallow the capsule or tablet whole with a glass of water. It can be taken with or without food.
  • Dosage: The dose will vary significantly based on the condition being treated, the patient's age (e.g., lower doses for older adults), and their response to the medication. Never take more or less of the medication than prescribed.
  • Frequency: Dosing for anxiety is commonly three or four times a day (e.g., every 6 to 8 hours), while for acute alcohol withdrawal, it may be three or four times daily, as determined by your doctor.

Key Considerations

  • Duration of Use: Benzodiazepines, including Tazepam, are generally recommended for short periods (e.g., 2 to 4 weeks). Prolonged use can lead to physical dependence, tolerance, and difficulty when stopping the medication.
  • Missed Dose: If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one.
  • Discontinuation: Never stop taking this medication abruptly, especially if you have been using it regularly for more than a few weeks. The dose must be gradually reduced under a doctor's supervision to prevent potentially severe withdrawal reactions.
  • Driving and Machinery: Tazepam may cause drowsiness or dizziness. Do not drive or operate heavy machinery until you know how the medication affects you.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tazepam


Evidence for Short-Term Symptomatic Relief of Anxiety

Research explored the use of Tazepam in individuals experiencing anxiety and emotional tension, relying primarily on short-term Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews. These studies are relevant in evidence describing how symptoms are measured in conditions characterized by fluctuating or episodic manifestations of anxiety. Researchers examined changes in standardized measurement tools, such as anxiety severity scales, to monitor outcomes capturing phases of heightened symptom activity.

Studies reported measurements of changes in these symptoms over defined time intervals, typically lasting four weeks or less. These findings were observed in populations with moderate-to-severe anxiety disorders. However, long-term effects are not fully established by existing high-quality studies. Follow-up durations were limited, and research exploring durability of response or maintenance of outcomes over many months is scarce.


Evidence for Managing Acute Alcohol Withdrawal Syndrome

Tazepam was studied for use during the acute phase of alcohol withdrawal syndrome (AWS), a condition associated with acute or disruptive episodes of physiological strain. The evidence base includes RCTs, Systematic Reviews, and Network Meta-Analyses. Research examined outcomes related to systemic imbalance and acute changes.

Findings describe patterns observed in the studies, including measurements of changes in the intensity of withdrawal symptoms, such as agitation and tremulousness. Regulatory bodies have cited evidence pertaining to the use of this compound in the setting of this specific, acute context. Research exploring longer-term rehabilitation outcomes following the acute withdrawal phase is not well established by the existing evidence.


Long-Term Evidence and Research Gaps

Most clinical evidence for Tazepam is derived from studies with short follow-up durations, typically four weeks or less. This duration is consistent with the short-term focus observed across the core studies. The data show patterns related to symptom changes observed during an acute or short-term period of use, but research provides context regarding group patterns, not individual predictions for long-term use. Data for long-term outcomes and maintenance therapy remain insufficient.

Research has explored the use of Tazepam in patient groups with compromised liver function and in older adults. However, data for certain groups remain insufficient. For instance, well-controlled research regarding use in children under six years of age is not available.

Key Studies & References DailyMed Label Information: Oxazepam Capsules

Frequently Asked Questions (FAQ)

Common questions about Tazepam (FAQ)


Q: Does Tazepam only help with falling asleep, or does it help with staying asleep, too?

Official indications list the management of anxiety and relief of symptoms such as tension and agitation. While the drug is sometimes prescribed for insomnia, the regulatory focus is on relieving underlying symptoms that may be associated with poor sleep. This means the effect on sleep is typically achieved by calming nervous activity rather than directly influencing specific sleep cycles.

Q: How quickly does Tazepam typically start to work after it is taken?

According to the official product information, the active ingredient's peak concentration in the bloodstream is usually reached about 3 hours after a dose is taken. This time frame is generally indicative of when the drug’s full effects are most noticeable.

Q: How long can the effects of Tazepam last into the next day?

Regulatory documents describe the drug's mean elimination half-life as approximately 8 hours. The half-life is the time it takes for half of the drug to be removed from the body. Because of this intermediate duration, the potential for residual effects is a possibility that should be considered.

Q: Is it normal to feel a 'hangover effect' or grogginess the morning after taking Tazepam?

Drowsiness, sedation, dizziness, and lethargy are commonly documented adverse effects in the official product information. These effects are a reported outcome associated with the medicine's function as a central nervous system depressant. These effects may slow thinking and motor skills, and in some patients, they may persist into the morning.

Q: Can Tazepam cause memory problems, like not recalling events right after taking it?

Official safety information reports that memory impairment and a form of temporary memory loss called anterograde amnesia are side effects correlated with the use of benzodiazepine medicines like Tazepam. These are listed as potential adverse effects that should be noted.

Q: What are the reported 'complex sleep behaviors' like sleep-driving mentioned in warnings?

Official regulatory cautions for this class of medicine address sleep-related hazardous activities. These reported behaviors include activities performed while not fully awake, such as driving, making phone calls, or preparing and eating food. This warning highlights the importance of not driving or operating machinery until the patient knows how the medicine affects them.

Q: Are there different types of allergic reactions associated with Tazepam?

Regulatory safety information lists severe symptoms that would require immediate medical attention if they occur. These signs of a serious reaction include difficulty breathing or swallowing, a severe skin rash, and swelling of the lips, mouth, tongue, or throat.

Q: Can Tazepam be taken with common over-the-counter pain relievers?

Official interaction maps primarily caution against concurrent use with other central nervous system (CNS) depressants. While the label does not specifically address every over-the-counter pain reliever, official guidance suggests that patients consider whether the pain reliever has any sedating effects.

Q: Is there a known interaction between Tazepam and certain antidepressant medicines?

According to the official product information, patients should be warned that the effects of other Central Nervous System (CNS) depressants may be additive. Because certain antidepressant medicines also work on the CNS, concurrent use may increase the risk of profound sedation or slowed breathing.

Q: What does the drug's classification as a 'controlled substance' mean for the patient?

Oxazepam is a federal controlled substance (C-IV). This classification is used because the medicine has the potential for abuse or can lead to dependence. Official guidance states that it should be kept in a safe place and not shared with others to prevent misuse.

Q: What kind of mental health conditions are listed as cautions for using Tazepam?

Official warnings advise caution in patients with pre-existing conditions, including depression and suicide ideation, as well as a history of substance abuse. Regulatory documents also note that paradoxical reactions, such as increased aggression or confusion, have been reported.

Q: What are the common symptoms of withdrawal if Tazepam use is stopped too suddenly?

If use is stopped too quickly, official warnings indicate a risk of acute withdrawal reactions. These symptoms may include, but are not limited to, seizures, anxiety, insomnia, tremors, sweating, abdominal and muscle cramps, nausea, vomiting, and depression.

Q: Can long-term use of Tazepam affect cognitive function beyond memory loss?

The official labels state that the effectiveness of the drug in long-term use (defined as more than 4 months) has not been assessed by systematic clinical studies. The lack of long-term data is the basis for the regulatory statement that the usefulness of the drug should be periodically reassessed when used for extended periods.

Q: Does Tazepam affect blood pressure or heart rate?

Regulatory documents list low blood pressure (hypotension) as a potential adverse effect. This side effect is noted as a particular concern in older adults. If there are concerns about blood pressure or heart rate, this information should be communicated to a healthcare professional.

Q: Is nausea a frequent side effect reported with Tazepam use?

Nausea and vomiting are listed among the possible side effects in the official product information. While these effects are not classified as the most common, they are documented adverse reactions.

Q: Can Tazepam worsen symptoms of depression?

According to official safety information, depression is listed as a potential side effect, and new or increased feelings of anxiety, depression, or other unusual changes in mood or behavior is information that should be communicated to a healthcare provider.

Q: Can Tazepam cause dry mouth?

Dry mouth is listed among the adverse effects.

How should Tazepam be stored and disposed of?

Storage and Disposal of Tazepam

The storage and disposal instructions for Tazepam (oxazepam) are based strictly on official regulatory requirements to maintain product quality and safety.


Official Storage Requirements

Storage Factor Requirement
Temperature Store at controlled room temperature (20 C to 25 C), with permissible excursions between 15 C and 30 C.
Protection Must be protected from moisture and kept in a tight container in a dry place.
Safety Keep this and all medicines out of the reach of children.

Disposal Instructions

Unused or expired Tazepam must be disposed of according to local regulations. The FDA advises mixing the medication with an undesirable substance (such as dirt or coffee grounds) and sealing it in a plastic bag before placing it in the household trash to mitigate misuse risk.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tazepam found in:

A-Z Index: